Odonate Therapeutics Stock Cash Per Share
| ODTCDelisted Stock | USD 1.80 0.00 0.00% |
Odonate Therapeutics fundamentals help investors to digest information that contributes to Odonate Therapeutics' financial success or failures. It also enables traders to predict the movement of Odonate Pink Sheet. The fundamental analysis module provides a way to measure Odonate Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Odonate Therapeutics pink sheet.
Odonate |
Odonate Therapeutics Company Cash Per Share Analysis
Odonate Therapeutics' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Odonate Therapeutics Cash Per Share | 2.47 X |
Most of Odonate Therapeutics' fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Odonate Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, Odonate Therapeutics has a Cash Per Share of 2.47 times. This is 93.12% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The cash per share for all United States stocks is 50.7% higher than that of the company.
Odonate Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Odonate Therapeutics' direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Odonate Therapeutics could also be used in its relative valuation, which is a method of valuing Odonate Therapeutics by comparing valuation metrics of similar companies.Odonate Therapeutics is currently under evaluation in cash per share category among its peers.
Odonate Fundamentals
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | (26.67 M) | ||||
| Shares Outstanding | 38.49 M | ||||
| Shares Owned By Insiders | 3.61 % | ||||
| Shares Owned By Institutions | 9.60 % | ||||
| Number Of Shares Shorted | 379.63 K | ||||
| Price To Book | 0.89 X | ||||
| EBITDA | (125.91 M) | ||||
| Net Income | (126.35 M) | ||||
| Cash And Equivalents | 95.03 M | ||||
| Cash Per Share | 2.47 X | ||||
| Total Debt | 4.85 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 3.29 X | ||||
| Book Value Per Share | 1.85 X | ||||
| Cash Flow From Operations | (113.13 M) | ||||
| Short Ratio | 0.59 X | ||||
| Earnings Per Share | (2.71) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 137 | ||||
| Beta | 0.0342 | ||||
| Market Capitalization | 69.28 M | ||||
| Total Asset | 167.89 M | ||||
| Z Score | 8.4 | ||||
| Net Asset | 167.89 M |
About Odonate Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Odonate Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Odonate Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Odonate Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Odonate Pink Sheet
If you are still planning to invest in Odonate Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Odonate Therapeutics' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |